Skip to main content

Terry Hyslop

Adjunct Professor in the Department of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Translational Biomedical
Duke Box 2717, Durham, NC 27710
130 S 9th St, Philadelphia, PA 19107

Selected Grants


Integrating Biology and Access to Understand Metastatic Breast Cancer Disparities

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2022 - 2025

IRONMAN: ENHANCING SURVIVORSHIP IN MEN WITH ADVANCED PROSTATE CANCER

ResearchBiostatistician · Awarded by Harvard T.H. Chan School of Public Health · 2023 - 2025

Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS

ResearchInvestigator · Awarded by Alliance for Clinical Trials in Oncology Foundation · 2016 - 2023

Integrating Biology and Access to Understand Metastatic Breast Cancer Disparities

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2022 - 2025

IRONMAN: ENHANCING SURVIVORSHIP IN MEN WITH ADVANCED PROSTATE CANCER

ResearchBiostatistician · Awarded by Harvard T.H. Chan School of Public Health · 2023 - 2025

Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS

ResearchInvestigator · Awarded by Alliance for Clinical Trials in Oncology Foundation · 2016 - 2023

Targeting RNA splicing in race-related aggressive and lethal prostate cancer

Clinical TrialBiostatistician · Awarded by Prostate Cancer Foundation · 2018 - 2023

Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer

ResearchCollaborator · Awarded by Department of Defense · 2020 - 2022

Translational Research in Surgical Oncology

Inst. Training Prgm or CMECo-Mentor · Awarded by National Institutes of Health · 2002 - 2022

Epigenetic damage in women living in LA food-desert zip codes

ResearchPrincipal Investigator · Awarded by City of Hope · 2017 - 2022

Combined breast MRI/biomarker strategies to identify aggressive biology

ResearchPrincipal Investigator · Awarded by City of Hope · 2015 - 2022

Microscaled Proteogenomics for Cancer Clinical Trials

ResearchPrincipal Investigator · Awarded by Baylor College of Medicine · 2017 - 2022

Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer

ResearchCollaborator · Awarded by National Institutes of Health · 2020 - 2021

Intergovernmental Personnel Agreements (IPA) - Gu

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2021

Tension-Stat3-miR-mediated Metastasis

ResearchPrincipal Investigator · Awarded by City of Hope · 2015 - 2021

Helicobacter pylori blood biomarker for gastric cancer risk in East Asia

ResearchBiostatistician Investigator · Awarded by National Institutes of Health · 2017 - 2020

Innovative Biomarker-Integrated Clinical Trial Design and Analysis

ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2015 - 2020

Personal Service Agreement (PSA) Gu

ResearchPrincipal Investigator · Awarded by Institute for Medical Research, Inc. · 2018 - 2019

Intergovernmental Personnel Agreements (IPA) Han

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2019

IPA - Terry Hyslop

ResearchResearch Associate · Awarded by Durham Veterans Affairs Medical Center · 2017 - 2019

IPA - Lin Gu

ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2017 - 2018

Tension-Stat3-miR-mediated Metastasis

ResearchPrincipal Investigator · Awarded by City of Hope · 2015 - 2018

Joint Analysis of CALGB and LEA Study

ResearchPrincipal Investigator · Awarded by Alliance for Clinical Trials in Oncology Foundation · 2015 - 2017

National Clinical Trials Network - Network Group Statistics and DMCs

ResearchStatistician · Awarded by Mayo Clinic · 2014 - 2017

Tension-Stat3-miR-mediated Metastasis

ResearchPrincipal Investigator · Awarded by City of Hope · 2015 - 2017

Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia

ResearchBiostatistician · Awarded by National Institutes of Health · 2015 - 2017

Small RNA Sequencing and prospective evaluation of HCC risk in HBV patients

ResearchPrincipal Investigator · Awarded by Thomas Jefferson University · 2014 - 2016

Combined breast MRI/biomarker strategies to identify aggressive biology

ResearchBiostatistician · Awarded by National Institutes of Health · 2015 - 2015

Tension-Stat3-miR-mediated metastasis

ResearchBiostatistician · Awarded by University of California - San Francisco · 2015 - 2015

Structural Models of Breast Cancer Outcomes Disparities

ResearchPrincipal Investigator · Awarded by Susan G Komen for the Cure · 2014 - 2015

Therapy-relevant stratification of breast cancer patients: Integrating pathology and biomarkers analysis

ResearchPrincipal Investigator · Awarded by Thomas Jefferson University · 2014 - 2015

Occult tumor burden as a marker stratifying therapy to eliminate racial disparities in colon cancer

ResearchPrincipal Investigator · Awarded by Thomas Jefferson University · 2014 - 2014

Tumor MicroRNA Signatures as Prognostic Biomarkers of Colorectal Cancer

ResearchPrincipal Investigator · Awarded by Thomas Jefferson University · 2014 - 2014

Therapeutic vaccine bridging the gap in racial disparities in colorectal cancer

ResearchPrincipal Investigator · Awarded by Thomas Jefferson University · 2014 - 2014

External Relationships


  • City of Hope
  • Medical College of Wisconsin
  • Medical University of South Carolina
  • The University of North Carolina at Chapel Hill
  • University of California, San Francisco
  • City of Hope
  • Medical College of Wisconsin
  • Medical University of South Carolina
  • The University of North Carolina at Chapel Hill
  • University of California, San Francisco
  • University of South Carolina
  • VCU Massey Cancer Center

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.